853910-08-4Relevant academic research and scientific papers
Imidazo-quinoline derivative and application thereof
-
Paragraph 0044, (2018/11/22)
The invention relates to application of PI3 kinase and mTOR (Mammalian Target of Rapamycin) dual inhibitor, namely an imidazo-quinoline derivative, in treating PI3 kinase and mTOR kinase dependency diseases of mammals, or application of the inhibitor in preparing medicine compositions for treating diseases, a use method of the specific imidazo-quinoline derivative in treating diseases of warm-blooded animals, particularly human beings, and application of a medicine preparation which is used for treating the diseases and comprises the specific imidazo-quinoline derivative.
NOVEL BENZAMIDE DERIVATIVES AS MODULATORS OF THE FOLLICLE STIMULATING HORMONE
-
Page/Page column 134, (2008/12/04)
The present invention provides new compounds of formula I, wherein Q, R1, R2, R4, R5, R6, Xi, R7, R8, M and G1 nare defined as in formula I; invention compounds are modulators of follicle-stimulating hormone - ("FSH") which are useful for male and female contraception as well as other disorders modulated by FSH receptor.
1H-IMIDAZO[4,5-C]QUINOLINE DERIVATIVES IN THE TREATMENT OF PROTEIN KINASE DEPENDENT DISEASES
-
Page/Page column 100, (2010/02/12)
The invention relates to the use of imidazoquinolines and salts thereof in the treatment of protein kinase diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases, imidazoquinolines for use in the treatment of protein kinase dependent diseases, a method of treatment against said diseases, comprising administering the imidazoquinolines to a warm-blooded animal, especially a human, pharmaceutical preparations comprising an imidazoquinoline, especially for the treatment of a protein kinase dependent disease, novel imidazoquinolines, and a process for the preparation of the novel imidazoquinolines.
